Search

everythinglearnresearchcommunity

for

Search:↓

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

Araliadiol may promote hair growth like minoxidil without being toxic.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

PPAR alpha may help in hair growth and could be a target for treatment.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Early regulatory T cells are crucial for normal skin pigmentation.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Fat tissue and a specific protein are crucial for healthy hair growth and maintenance.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Piperine from black pepper can make hair less oily by blocking fat cell development in hair roots.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.